User menu

19F NMR in vivo spectroscopy reflects the effectiveness of perfusion-enhancing vascular modifiers for improving gemcitabine chemotherapy

Bibliographic reference Cron, Greg O. ; Beghein, Nelson ; Ansiaux, Réginald ; Martinive, Philippe ; Feron, Olivier ; et. al. 19F NMR in vivo spectroscopy reflects the effectiveness of perfusion-enhancing vascular modifiers for improving gemcitabine chemotherapy. In: Magnetic Resonance in Medicine, Vol. 59, no. 1, p. 19-27 (2008)
Permanent URL http://hdl.handle.net/2078.1/11211
  1. van Laarhoven, Crit Rev Oncol Hematol, 56, 321 (2005)
  2. Yu, Curr Med Chem, 12, 819 (2005)
  3. Martino, Curr Drug Metab, 1, 271 (2000)
  4. Robinson S P, Barton S J, McSheehy P M J, Griffiths J R, Nuclear Magnetic Resonance Spectroscopy of Cancer, 10.1259/bjr.1997.0009
  5. van Laarhoven, Cancer Res, 63, 7609 (2003)
  6. Dzik-Jurasz, Magn Reson Med, 44, 516 (2000)
  7. Wolf, Adv Drug Deliv Rev, 41, 55 (2000)
  8. van Laarhoven, Neoplasia, 8, 477 (2006)
  9. McSheehy, Cancer Chemother Pharmacol, 55, 117 (2005)
  10. Kamm, Br J Cancer, 89, 754 (2003)
  11. Kamm, Eur J Cancer, 36, 1180 (2000)
  12. Katzir, Cancer Invest, 18, 20 (2000)
  13. Lemaire, Cancer Chemother Pharmacol, 42, 201 (1998)
  14. McSheehy, Cancer Res, 58, 1185 (1998)
  15. McSheehy, Eur J Cancer, 33, 2418 (1997)
  16. Holland, Magn Reson Med, 38, 907 (1997)
  17. Blackstock, Int J Radiat Oncol Biol Phys, 36, 641 (1996)
  18. Kamm, Cancer Res, 54, 4321 (1994)
  19. Shungu, Magn Reson Med, 28, 105 (1992)
  20. McSheehy PMJ, Prior MJW, Griffiths JR, Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo, 10.1038/bjc.1989.275
  21. Blackstock, Clin Cancer Res, 7, 3263 (2001)
  22. Kristjansen, Ann Oncol, 4, 157 (1993)
  23. Brix, Magn Reson Med, 34, 302 (1995)
  24. Brunstein, Ann Surg Oncol, 14, 795 (2007)
  25. Gupta, Clin Cancer Res, 12, 3115 (2006)
  26. Sonveaux, Cancer Res, 64, 3209 (2004)
  27. Ansiaux, Clin Cancer Res, 11, 743 (2005)
  28. Segers, Cancer Lett, 244, 129 (2006)
  29. Jain, Nat Med, 7, 987 (2001)
  30. Ansiaux, Clin Cancer Res, 12, 1276 (2006)
  31. Carducci, J Clin Oncol, 21, 679 (2003)
  32. Michaelson, Cancer, 107, 530 (2006)
  33. Figg William D., Li Haiqing, Sissung Tristan, Retter Avi, Wu Shenhong, Gulley James L., Arlen Phil, Wright John J., Parnes Howard, Fedenko Kathy, Latham Lea, Steinberg Seth M., Jones Elizabeth, Chen Clara, Dahut William, Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer, 10.1111/j.1464-410x.2007.06763.x
  34. Klein, Dermatol Surg, 29, 549 (2003)
  35. Taper, Cancer Res, 26, 143 (1966)
  36. Fields, Int J Radiat Oncol Biol Phys, 47, 785 (2000)
  37. Gudbjartsson, Magn Reson Med, 34, 910 (1995)
  38. Hayes, NMR Biomed, 15, 154 (2002)